Amazing set of number by Neuland Labs.
Highest revenue share from CMS segment.
All time high margin although it can vary QoQ.
Huge debt reduction
Number of CMS phase 2 molecules doubled YoY.
Concall - Working on few peptides in both NCE and also for generic.
Can create more capacities in Unit 3
Years of efforts in CMS is showing its results now.
Subscribe To Our Free Newsletter |